Guha Mazumdar Papiya, Gupta Kamla
International Institute for Population Sciences, Mumbai, India.
J Biosoc Sci. 2007 Nov;39(6):819-41. doi: 10.1017/S0021932007002106. Epub 2007 May 31.
India has a strong base of ancient indigenous systems of medicine and its national health policies and programmes have consistently promoted the integration of Indian Systems of Medicine (ISM) into the country's official health system. Realizing the safety and efficacy of ISM drugs, the Department of Indian Systems of Medicine and Homoeopathy (ISM&H) has suggested their use for certain women's health problems and during pregnancy. Although the Government of India has attempted to integrate ISM through the country's contemporary health programme of Reproductive and Child Health (RCH), utilization dynamics from the clients' perspective is little understood. This study shows that, at least in urban areas, for the majority of women's health problems biomedicine is regarded as the first choice, failure of which leads clients to seek treatment from ISM as a final resort. Nevertheless, women showed a preference for ISM treatment for certain specific health problems, strongly backed by a belief in their efficacy. Of the predictors that positively influenced women's choice of ISM treatment, 'strong evidenced-based results' was found to be the most important. Women's preference for ISM is dependent on the availability of competent providers.
印度拥有强大的古代本土医学体系基础,其国家卫生政策和计划一直致力于推动印度医学体系(ISM)融入该国的官方卫生系统。鉴于ISM药物的安全性和有效性,印度医学与顺势疗法部(ISM&H)建议将其用于某些妇女健康问题及孕期。尽管印度政府试图通过该国当代的生殖与儿童健康(RCH)计划来整合ISM,但从客户角度来看的利用动态却鲜为人知。本研究表明,至少在城市地区,对于大多数妇女健康问题,生物医学被视为首选,若生物医学治疗失败,客户才会寻求ISM治疗作为最后手段。然而,妇女对某些特定健康问题表现出对ISM治疗的偏好,这种偏好因坚信其疗效而得到有力支持。在对妇女选择ISM治疗产生积极影响的预测因素中,“强有力的循证结果”被认为是最重要的。妇女对ISM的偏好取决于是否有称职的医疗服务提供者。